Therapeutic Phlebotomy Guidelines

Condition-Specific Cutoffs

The National Comprehensive Cancer Network recommends maintaining hematocrit strictly below 45% for all patients with polycythemia vera (PV), with a lower target of approximately 42% for women and African Americans due to physiological differences in baseline hematocrit values 1, 2, 3
For patients with PV, the American College of Physicians suggests considering a lower target hematocrit of 42% for women and African Americans 2, 3
The National Comprehensive Cancer Network guidelines are based on the CYTO-PV study, which showed reduced thrombotic complications with hematocrit <45% 4, 3
For low-risk PV, the National Comprehensive Cancer Network recommends phlebotomy + low-dose aspirin (81-100 mg/day) 4
For high-risk PV, the National Comprehensive Cancer Network recommends phlebotomy + low-dose aspirin + cytoreductive therapy 5
For patients with congenital heart disease with cyanosis, the American Heart Association indicates that therapeutic phlebotomy is indicated when hemoglobin >20 g/dL AND hematocrit >65% 6
The American Heart Association advises only performing phlebotomy when symptoms of hyperviscosity are present (headache, fatigue) in patients with congenital heart disease with cyanosis 6
For secondary polycythemia, the National Comprehensive Cancer Network suggests considering phlebotomy when hematocrit exceeds 52-55% 3

The Mayo Clinic recommends removing one unit of blood (approximately 500 mL) per session and providing appropriate fluid replacement to avoid hypotension or fluid overload 2, 3, 7
Each unit of blood contains approximately 200-250 mg of iron, according to the National Comprehensive Cancer Network 7
The National Comprehensive Cancer Network advises checking hemoglobin/hematocrit before each phlebotomy session 7
For PV patients, the National Comprehensive Cancer Network recommends monitoring for signs/symptoms of disease progression every 3-6 months 4
For hemochromatosis, the National Comprehensive Cancer Network suggests monitoring serum ferritin every 10-12 phlebotomies during the initial phase 7

The Mayo Clinic recommends using more caution with fluid replacement in elderly patients and considering cytoreductive therapy if phlebotomy is poorly tolerated 2, 4
Iron deficiency from excessive phlebotomy can lead to microcytosis and increased stroke risk, according to the American Heart Association 6
Patients with cardiovascular disease require careful monitoring during phlebotomy, as recommended by the Mayo Clinic 2